Hocks, Harleys, and a whole lot of hope will color in the week that lies ahead.

With Pittsburgh Steelers quarterback Ben Roethlisberger admitting this week that he was seconds away from dying after a springtime motorcycle accident, let's hope he learns his lesson and wears a helmet the next time he decides to go for a ride. If not, my more market-friendly advice would be that it would be safer for Ben to own shares in Harley-Davidson (NYSE:HDI) than to ride a Harley without protective headwear.

Want proof? Check in on Monday, when the company is expected to post earnings of $0.91 per share after a showing of $0.84 a year earlier. The shares have been nearly a 50-bagger since 1990.

It's true that washing down Pop Rocks with Coke won't explode in your innards. What about washing down Yahoo! (NASDAQ:YHOO) with Coca-Cola (NYSE:KO)? You'll get that chance on Tuesday, as the two giants step up for their quarterly updates.

Naturally, the market will turn to Yahoo! for insight on the state of online advertising. Coke, a recommended stock for Motley Fool Inside Value newsletter subscribers, is likely to provide more predictable results but will still give us a provocative glimpse into soda-consumption habits.

The middle of the week will bid for your attention thanks to eBay's (NASDAQ:EBAY) meaty report. The popular Motley Fool Stock Advisor selection is trading at a three-year low at the moment, so disappointed investors in the leading online auctioneer would sorely welcome any kind of good news.

Maybe part of eBay's malaise can be tied to Thursday's reporting star, Google (NASDAQ:GOOG). Its Google Checkout may be a threat to eBay's PayPal. Google Base has the potential to disrupt eBay's namesake marketplace business.

Beyond that, Google has every right to stand on its own. It has completely trounced analyst estimates in six of its first seven quarters as a public company. Just when you think the shares are pricey -- and a lot of you out there certainly believe that to always be the case -- the company comes through with a stellar quarterly snapshot to prop the shares higher. Will the good times end on Thursday? Stick around to find out.

Remember when the major pharmaceuticals were easy money? Through most of the 1990s, it seemed as though you couldn't go wrong snapping up shares of the big drug manufacturers. It was a defensive play with a growth kick to boot. The climate hasn't been as kind in recent years, and that brings us to Eli Lilly (NYSE:LLY) closing out the trading week with its second-quarter report. The company behind the Prozac antidepressant and Cialis erectile-dysfunction treatment is looking to earn $0.75 a share for the period. That would be a healthy improvement over the $0.67 per share it earned a year ago.

Until next week, I remain,

Rick Munarriz

Eli Lilly is a Motley Fool Income Investor recommendation. Coca-Cola is a Motley Fool Inside Value pick, and eBay is a Motley Fool Stock Advisor selection. Try out any of our investing newsletters free for 30 days.

Longtime Fool contributor Rick Munarriz recommends windshield wiper fluid when trying to look forward. He does not own shares in any of the companies in this story. The Fool has a disclosure policy. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.